Cohen, Julia
https://orcid.org/0000-0003-2048-8915
Mayo Clinic
Merck & Co., Inc., Rahway, NJ, USA (United States)
Citations 1
722 Immunoprofiling and correlative analysis from PROTA: a phase I trial combining an oncolytic adenovirus encoding TNFα and IL2 with pembrolizumab for platinum-resistant or refractory ovarian cancer
Santos, Joao, Pakola, Santeri A, Heijden, Mirte Van der, Quixabeira, Dafne Alves, Block, Matthew S. , Mäenpää, Johanna , Cohen, Julia , Kononen, Juha , Haybout, Lyna , Havunen, Riikka , Goldfinch, John, Kistler, Claudia , Sorsa, Suvi , Clubb, James H.A. , Jirovec, Elise , Arias, Victor , Kudling, Tatiana Viktorovna , Cohen, Julia, Chisamore, Michael Jon , Adamo, Daniel A. , Alanko, Tuomo , Sormunen, Jorma , Cervera-Carrascón, Víctor , Hemminki, Akseli
Regular and Young Investigator Award Abstracts | November 5, 2024 | Volume: No volume available | Issue: No issue available | Pages: A824-A824
